BackRecordati Industria Chimica e Farmaceutica S.p.A. Overview

Recordati Industria Chimica e Farmaceutica S.p.A. Receivables

Latest receivables for REC.MI: $640M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$637.43M
↓ 8.91% YoYΔ $-62.33M vs prior year quarter

Peer trimmed avg / median

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. Receivables History

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. vs. peers: Receivables Comparison

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI) FAQ

The latest receivables for REC.MI is $640M as of September 2026. That compares with $700M in the prior-year period — down 8.9% year over year. Investors often review this figure alongside Recordati Industria Chimica e Farmaceutica S.p.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, REC.MI's receivables moved from $700M to $640M — a 8.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Recordati Industria Chimica e Farmaceutica S.p.A.'s operating scale or balance-sheet position.

A receivables figure of $640M for REC.MI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting REC.MI's receivables ($640M), review year-over-year change from $700M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.